Hausstaubmilben (V01AA03)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter KKH) pursues the objective of concluding discount contracts pursuant to § 130a(8) of SGB V with all suitable pharmaceutical companies for the active ingredient stated under BT-21-Lot (ATC) and, if applicable, restricting them to certain dosage forms, within a so-called "Open-House procedure". Subject to uniform contract terms and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the conclusion of, or accession to, a discount contract pursuant to § 130a(8) of SGB V for the above-mentioned active ingredient. Interested pharmaceutical companies may request the participation documents and the contract for this purpose at the above contact address. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the requested participation documents in full and duly completed and signed. A contract is concluded with each pharmaceutical company that meets the participation requirements. Exclusivity is not provided. Accession and contract conclusion may be made at any time under the same conditions. Individual…

TENDER BRIEF

TENDER DOCUMENTS